In addition to this, it has been reported that increased quantities of soluble MUC16 were found in a variety of cancers, including breast cancer, mesothelioma, gastric cancer, colorectal adenocarcinoma, and some others [19, 33–35]. This evidence concerns the gene MUC16 and breast carcinoma.